ArticleEuropean journal of nuclear medicine and molecular imaging2022

Measuring response in metastatic castration-resistant prostate cancer using PSMA PET/CT: comparison of RECIST 1.1, aPCWG3, aPERCIST, PPP, and RECIP 1.0 criteria.

Andrei Gafita et al.PubMed ↗Publisher ↗

No numbers read from the abstract.